Ahead Of Second Quarter Earnings Call, Gilead CEO Resigns

Just before Gilead Sciences released its second quarter earnings Wednesday after the close of markets, the company announced in a separate statement that CEO John Milligan has resigned.

Read the full post on Forbes - Healthcare